tiprankstipranks
InnoCan Pharma (TSE:INNO)
CNQX:INNO
Holding TSE:INNO?
Track your performance easily

InnoCan Pharma (INNO) Technical Analysis

11 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
4Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
InnoCan Pharma’s (INNO) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting InnoCan Pharma is a Sell.
InnoCan Pharma’s (INNO) 20-Day exponential moving average is 0.21, while InnoCan Pharma’s (INNO) share price is C$0.19, making it a Buy.
InnoCan Pharma’s (INNO) 50-Day exponential moving average is 0.21, while InnoCan Pharma’s (INNO) share price is C$0.19, making it a Sell.

InnoCan Pharma (INNO) Pivot Points

Jan 10, 2025, 03:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.20
0.20
0.20
0.20
0.20
0.20
0.20
Fibonacci
0.20
0.20
0.20
0.20
0.20
0.20
0.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

InnoCan Pharma (INNO) Moving Averages

Jan 10, 2025, 03:14 PM
Period
Simple
Exponential
MA5
0.21Buy
0.20Buy
MA10
0.20Buy
0.20Buy
MA20
0.20Buy
0.21Buy
MA50
0.21Sell
0.21Sell
MA100
0.22Sell
0.22Sell
MA200
0.25Sell
0.25Sell
InnoCan Pharma’s (INNO) 10-Day exponential moving average is 0.20, while InnoCan Pharma’s (INNO) share price is C$0.19, making it a Buy.
InnoCan Pharma’s (INNO) 100-Day exponential moving average is 0.22, while InnoCan Pharma’s (INNO) share price is C$0.19, making it a Sell.
InnoCan Pharma’s (INNO) stock price is C$0.19 and InnoCan Pharma’s (INNO) 50-day simple moving average is 0.21, creating a Sell signal.
InnoCan Pharma’s (INNO) stock price is C$0.19 and InnoCan Pharma’s (INNO) 100-day simple moving average is 0.22, creating a Sell signal.
InnoCan Pharma’s (INNO) stock price is C$0.19 and InnoCan Pharma’s (INNO) 200-day simple moving average is 0.25, creating a Sell signal.

InnoCan Pharma (INNO) Technical Indicators

Jan 10, 2025, 03:14 PM
Name
Value
Implied Action
RSI (14)
51.38
Neutral
STOCH (9,6)
86.67
Sell
STOCHRSI (14)
86.67
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
54.21
Sell
Williams %R
0.00
-
CCI (14)
57.88
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
72.22
Buy
ROC
0.00
-
InnoCan Pharma’s (INNO) Relative Strength Index (RSI) is 51.38, creating a Neutral signal.
InnoCan Pharma’s (INNO) Trend Strength Indicator (ADX) is 54.21, creating a Sell signal.
InnoCan Pharma’s (INNO) Commodity Channel Index (CCI) is 57.88, creating a Neutral signal.

FAQ

Is INNO a Buy, Hold, or Sell?
Based on INNO’s technical indicators, INNO is a Sell.
    What is INNO’s RSI (14)?
    INNO’s RSI (14) is 51.38, which suggests INNO is a Neutral.
      What is INNO’s MACD?
      INNO’s MACD is >-0.01, which suggests INNO is a Sell.
        What is INNO’s 5-day moving average?
        INNO’s 5-day moving average is 0.21, which suggests INNO is a Buy.
          What is INNO’s 20-day moving average?
          INNO 20-day moving average is 0.20, which suggests INNO is a Buy.
            What is INNO’s 50-day moving average?
            INNO’s 50-day moving average is 0.21, which suggests INNO is a Sell.
              What is INNO’s 200-day moving average?
              INNO’s 200-day moving average is 0.25, which suggests INNO is a Sell.
                What is INNO’s Williams % R (14)?
                Currently, no data Available
                What is INNO’s CCI (14)?
                INNO’s CCI (14) is 57.88, which suggests INNO is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis